This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by De Potter, C. R. Articles by van Emmelo, J. Search for Related Content PubMed PubMed Citation Articles by De Potter, C. R. Articles by van Emmelo, J.

American Journal of Pathology, Vol 144, 95-103, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

A monoclonal antibody directed against a human cell membrane antigen prevents cell substrate adhesion and tumor invasion

CR De Potter, AM Schelfhout, FH De Smet, S Van Damme, L de Ridder, E Dhont and J van Emmelo
N. Goormaghtigh Institute for Pathology, University Hospital, Ghent, Belgium.

It was the aim of this study to design mouse monoclonal antibodies (MAbs) that can inhibit the invasion of breast cancer cells in the host tissue. Therefore, MAbs were raised against epitopes on the extracellular domain of SK-BR-3 human breast cancer cells, and biological assays were performed to test the capability of the MAbs to inhibit cell substrate adhesion. MAb 14C5 bound an extracellular plasma membrane antigen of SK-BR-3 and MCF-7 human breast cancer cells and inhibited the cell substrate adhesion of these cells in vitro. The MAb delayed the adhesion of MCF-7 and SK-BR-3 cells on precultured embryonic heart fragments (PHFS). It inhibited the destruction of the PHF by MCF-7 cells and the invasion of the PHF by SK-BR-3 cells. The MAb reacted with an epitope on the cell membrane of in situ and invasive ductal carcinomas of the breast in immunohistochemistry. Poorly differentiated, highly invasive ductal carcinomas show extensive staining of long plasma membrane extensions. Normal multilayered epithelia, normal connective tissue, and tumors derived from these tissues as well as normal breast tissue were negative. From both cell lines a protein complex consisting of two subunits with molecular weight of 50 and 90 kd, respectively, was immunoprecipitated. It is concluded that the 14C5 antigen plays a role in cell substrate adhesion and subsequently also in invasion of breast cancer cells. The 14C5 MAb was able to inhibit cell substrate adhesion and invasion in vitro of breast cancer cells.

This article has been cited by other articles:

				I. Burvenich, S. Schoonooghe, B. Cornelissen, P. Blanckaert, E. Coene, C. Cuvelier, N. Mertens, and G. Slegers In vitro and In vivo Targeting Properties of Iodine-123- or Iodine-131-Labeled Monoclonal Antibody 14C5 in a Non-Small Cell Lung Cancer and Colon Carcinoma Model Clin. Cancer Res., October 15, 2005; 11(20): 7288 - 7296. [Abstract] [Full Text] [PDF]

				C. M.M. Lahorte, K. Bacher, I. Burvenich, E. D. Coene, C. Cuvelier, C. De Potter, H. Thierens, C. Van de Wiele, R. A. Dierckx, and G. Slegers Radiolabeling, Biodistribution, and Dosimetry of 123I-mAb 14C5: A New mAb for Radioimmunodetection of Tumor Growth and Metastasis In Vivo J. Nucl. Med., June 1, 2004; 45(6): 1065 - 1073. [Abstract] [Full Text] [PDF]

				U. Wagner, S. Köhler, S. Reinartz, P. Giffels, J. Huober, K. Renke, H. Schlebusch, H.-J. Biersack, V. Möbus, R. Kreienberg, et al. Immunological Consolidation of Ovarian Carcinoma Recurrences with Monoclonal Anti-Idiotype Antibody ACA125: Immune Responses and Survival in Palliative Treatment : See The Biology Behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are Solid Tumor Anti-Idiotype Vaccines Ready for Prime Time? Clin. Cancer Res., 7:1112-1115, 2001. Clin. Cancer Res., May 1, 2001; 7(5): 1154 - 1162. [Abstract] [Full Text]